Dr Céline Gongora (Institut de cancérologie de Montpellier (IRCM), guest of Team 3, will give a seminar entitled: Reactivation of the STING pathway to improve the efficacy of immunotherapies (anti-PD-(L)1) in urothelial carcinoma models , June 21 at 11.00 - Rooms 1, 2, 3 - IRS2, Nantes
Catherine Rabu (team 3) will present her HDR entitled: Antigènes de tumeurs issus de LongNonCoding RNA: identification, modes d'expression et utilisation thérapeutique on June 16 at 14.30, rooms 1, 2, 3 at IRS2, Nantes.
Dr. Etienne Meunier (Institute of Pharmacology & Structural Biology (IPBS) will give a seminar entitled: Emerging innate immune sensors in microbial detection, on June 12 at 2:00 pm - Rooms 1, 2, 3 - IRS2, Nantes
"Investigating the interaction between T cell metabolism and physical ability in aged mice: translation to humans."
Dr Isabelle Satney (Centre Méditerranéen de Médecine Moléculaire) will give a seminar entitled: Study of the interaction between T cell metabolism and physical capacities in aged mice: transposition to humans, May 11 at 11:00 am - Rooms 1, 2, 3 - IRS2, Nantes
"Learning to train and to explain a deep survival model with large scale ovarian cancer transcriptomic data."
Dr Elena Menand Spirina (Institut de Cancérologie de l'Ouest) will give a seminar entitled: Learning to train and to explain a deep survival model with large scale ovarian cancer transcriptomic data, on April 13 at 14.30 - Amphi D. Escande at IRS-UN, Nantes
Dr. Guillaume Sarrabayrouse from UMR 8258 will give a seminar entitled: Evaluation of digestive homeostasis disturbances induced by recombinant erythropoietin treatment, on February 28 at 14.00 Rooms 1, 2, 3 at IRS2, Nantes
Dr. Karl Herbert Schaefer from the University of Kaiserslautern will give a seminar entitled: News from the Gut: how to investigate ENS and related diseases , on January 30 at 11.00 am Rooms 1, 2, 3 at IRS2, Nantes
The INCIT unit is pleased to announce that it has been awarded an ambitious European program on immunotherapy, bringing together 7 partners (including 2 biotechs) in 4 European countries. This program is coordinated by Frédéric ALTARE, Director of the UMR 1302, INCIT in Nantes. Project title: immunotherapy of inflammatory bowel diseases
Seminar of Dr Cédric Ménard (CHU de Rennes) will give a seminar on his recent work on Characterization of the immunomodulatory effects of lenalidomide in follicular lymphoma, on December 12 at 11.00 am Rooms 1, 2, 3 at IRS2, Nantes
Kathleen Ducoin (team 3) will present her thesis entitled: Etude des réponses lymphocytaires CD8 antitumorales et modulation par les " Immune Checkpoints " dans le cancer colorectal humain on December 2 at 14.00 at IRS2, Nantes